Victor Tapson
Physician · Cedars-Sinai Medical Center
Credentials: · · · ·
History
Research
Remdesivir for the Treatment of Covid-19 - Final Report
New England Journal of Medicine · 2020 · 5,321 citations
New England Journal of Medicine · 1996 · 2,085 citations
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
New England Journal of Medicine · 2021 · 1,404 citations
- VM
44 papers
34 papers
25 papers
- LR
24 papers
- RB
21 papers
20 papers · 7 as a resident
18 papers
17 papers
Grants
- 2021–2025
Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
National Heart, Lung, and Blood Institute · R44
PI · $2.8M · Translational Sciences, Inc.
- 2000–2006
Prospective Investigation of Pulmonary Embolism Dx-Ii
National Heart, Lung, and Blood Institute · U01
Contact PI · $600K · Duke University
Clinical trials
- 2020–2021
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
Principal investigator · Terminated · Phase 4
Cedars-Sinai Medical Center
- 2020–2028
Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)
Principal investigator · Active not recruiting
V-Wave Ltd
- 2019–2020
Principal investigator · Terminated · Phase 4
Victor Tapson, MD
- 2015–2020
Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
Principal investigator · Completed · Phase 4
Boston Scientific Corporation